B Group, Inc.
- SEC CIK
- 0002043476
- Latest filing
- Aug 14, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 17, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 15
- −2 vs. Q3 2025
- Portfolio value
- $134.9M
- +$30.4M (+29.0%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ADMAAdma Biologics, Inc. | COM | 2,457,542 | $44.8M | 33.2% | +45,000+1.9% | Added | History |
| CLLSCellectis S.A. | SPON ADS | 3,281,501 | $15.9M | 11.8% | 00.0% | Unchanged | History |
| PALIPalisade Bio, Inc. | COM | 4,500,000 | $10.6M | 7.8% | +4,500,000 | New | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,800,556 | $9.90M | 7.3% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 33,237 | $9.80M | 7.3% | +1,737+5.5% | Added | History |
| SGHTSight Sciences, Inc. | COM | 920,000 | $7.30M | 5.4% | −10,000−1.1% | Reduced | History |
| ZLABZai Lab Ltd | ADR | 400,000 | $7.06M | 5.2% | 00.0% | Unchanged | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 90,000 | $6.26M | 4.6% | +90,000 | New | History |
| ASMBAssembly Biosciences, Inc. | COM NEW | 175,706 | $5.98M | 4.4% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,500,000 | $4.09M | 3.0% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 100,000 | $3.28M | 2.4% | 00.0% | Unchanged | History |
| AURAAura Biosciences, Inc. | COM | 572,576 | $3.12M | 2.3% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 135,000 | $3.10M | 2.3% | 00.0% | Unchanged | History |
| ORKAOruka Therapeutics, Inc. | COM | 75,000 | $2.27M | 1.7% | 00.0% | Unchanged | History |
| APGEApogee Therapeutics, Inc. | COM | 20,000 | $1.51M | 1.1% | −15,000−42.9% | Reduced | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| REPLReplimune Group, Inc. | COM | – | $486.0K |
Sold out since Q3 2025 (4)
Positions held at the end of Q3 2025 that are gone from this filing.
| Security | Class | Shares in Q3 2025 | Value in Q3 2025 | % of portfolio in Q3 2025 | History |
|---|---|---|---|---|---|
| AKROAkero Therapeutics, Inc. | COM | 232,446 | $11.0M | 10.6% | History |
| NRX Pharmaceuticals, Inc.629444118 | *W EXP 05/24/202 | 3,000,000 | $4.46M | 4.3% | – |
| GAMEGameSquare Holdings, Inc. | COM | 250,000 | $169.7K | 0.2% | History |
| INSMINSMED Inc | COM PAR $.01 | 158 | $22.8K | <0.1% | History |